<DOC>
	<DOCNO>NCT00144495</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety recombinant human erythropoietin anemic cancer patient undergo chemotherapy .</brief_summary>
	<brief_title>A Study Recombinant Human Erythropoietin Anemic Cancer Patients Undergoing Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Cancer patient history myocardial , cerebral pulmonary infarction severe hypertension beyond control drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>